Category Specific RSS

paa

PharmAust completes dosing first cohort for MND treatment, patients respond positively

Every day, two people are diagnosed in Australia with a form of motor neurone disease (MND). MND entails a group…

3 years ago

The funs of chemistry: How this pharma company is tapping into lucrative waste management

Ever wondered how renewable fuel is made? Or how biodegradable plastics are created? There’s a lot that happens after you…

3 years ago

PharmAust shrinks proprietary tablet for use in COVID-19 trials

Good things come in small packages, like PharmAust’s (ASX: PAA) newest iteration of their monepantel (MPL) tablets.  The clinical stage…

4 years ago

PharmAust is putting a leash on canine cancer, and COVID-19

From high rise city apartments to the rolling hills of the countryside, you’re likely to find a dog or two…

4 years ago